Hoey Investments’s Ginkgo Bioworks DNA Stock Holding History

Hoey Investments’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$645	Hold	65	–	–	﹤0.01%	397
2026 Q1	$399	Hold	65	–	–	﹤0.01%	383
2025 Q4	$541	Hold	65	–	–	﹤0.01%	384
2025 Q3	$948	Hold	65	–	–	﹤0.01%	356
2025 Q2	$732	Hold	65	–	–	﹤0.01%	369
2025 Q1	$371	Hold	65	–	–	﹤0.01%	342
2024 Q4	$639	Sell	65 -935	-94%	-$8.01K	﹤0.01%	326
2024 Q3	$335	Buy	1,000 +975	+3,900%	+$9.77K	﹤0.01%	367
2024 Q2	$335	Hold	25	–	–	﹤0.01%	367
2024 Q1	$1.16K	Hold	25	–	–	﹤0.01%	310
2023 Q4	$1.69K	Hold	25	–	–	﹤0.01%	302
2023 Q3	$1.81K	Hold	25	–	–	﹤0.01%	305
2023 Q2	$1.86K	Hold	25	–	–	﹤0.01%	300
2023 Q1	$1.33K	Hold	25	–	–	﹤0.01%	309
2022 Q4	$1.69K	Hold	25	–	–	﹤0.01%	267
2022 Q3	$3K	Hold	25	–	–	﹤0.01%	278
2022 Q2	$2K	Buy	+25	New	+$3.05K	﹤0.01%	252

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Hoey Investments's DNA Position: Q2 2026 in Review

Hoey Investments held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 65 shares worth $645. The position accounts for ﹤0.01% of the portfolio, ranked #397.

Hoey Investments first reported a position in DNA in Q2 2022 and has held it in 17 quarters since. The position peaked at $3K in Q3 2022. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Hoey Investments held 65 shares of Ginkgo Bioworks worth $645 as of Q2 2026.
Hoey Investments left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #397 holding.
Hoey Investments first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 17 quarters since.
Hoey Investments's Ginkgo Bioworks position peaked at $3K in Q3 2022.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.